CORT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 20.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $8,700,754.07

Corcept Therapeutics Insider Trading History Chart

Corcept Therapeutics Share Price & Price History

^$54.85

▼ -0.15 (-0.27%)

As of 03/13/2025 05:00 PM ET

Days: 30 | 90 | 365

Corcept Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/3/2025	Joseph K. Belanoff	CEO	Sell	2,924	$60.91	$178,100.84	3,019,411
3/3/2025	Sean Maduck	Insider	Sell	18,303	$60.69	$1,110,809.07	85,622
2/10/2025	Daniel N. Swisher, Jr.	Director	Sell	2,200	$68.08	$149,776.00
1/10/2025	Daniel N. Swisher, Jr.	Director	Sell	2,200	$50.54	$111,188.00
1/2/2025	Sean Maduck	Insider	Sell	20,000	$50.39	$1,007,800.00	85,318
12/10/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$59.46	$130,812.00
11/22/2024	Joseph Douglas Lyon	Insider	Sell	1,411	$56.72	$80,031.92	8,494
11/11/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$59.88	$131,736.00
11/4/2024	William Guyer	Insider	Sell	3,394	$48.97	$166,204.18	5,796
11/1/2024	William Guyer	Insider	Sell	6,606	$48.97	$323,495.82	5,796
10/1/2024	Gary Charles Robb	Insider	Sell	11,000	$46.28	$509,080.00	22,772
9/3/2024	William Guyer	Insider	Sell	10,000	$35.30	$353,000.00	6,039
8/26/2024	Gary Charles Robb	Insider	Sell	3,101	$35.71	$110,736.71	23,190
8/1/2024	Daniel N. Swisher, Jr.	Director	Sell	150	$38.50	$5,775.00
8/1/2024	William Guyer	Insider	Sell	10,000	$38.67	$386,700.00	6,039
7/1/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$32.81	$72,182.00
7/1/2024	Joseph Douglas Lyon	Insider	Sell	5,000	$32.49	$162,450.00	9,290
6/3/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$30.21	$66,462.00
6/3/2024	Joseph Douglas Lyon	Insider	Sell	5,000	$30.18	$150,900.00	7,314
5/28/2024	Gary Charles Robb	Insider	Sell	11,000	$30.39	$334,290.00	20,203
5/13/2024	Sean Maduck	Insider	Sell	50,000	$28.00	$1,400,000.00	85,222
5/9/2024	Joseph Douglas Lyon	Insider	Sell	7,227	$26.00	$187,902.00	7,314
5/2/2024	Joseph Douglas Lyon	Insider	Sell	10,830	$26.00	$281,580.00	7,314
4/4/2024	Joseph Douglas Lyon	Insider	Sell	5,443	$26.00	$141,518.00	7,314
4/1/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$25.30	$55,660.00
4/1/2024	Joseph Douglas Lyon	Insider	Sell	500	$26.01	$13,005.00	7,314
3/27/2024	Sean Maduck	Insider	Sell	25,953	$25.01	$649,084.53	85,222
3/18/2024	Sean Maduck	Insider	Sell	17,219	$25.00	$430,475.00	75,222
3/1/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$23.59	$51,898.00
2/16/2024	Joseph Douglas Lyon	CAO	Sell	1,000	$26.00	$26,000.00	6,774
2/16/2024	Sean Maduck	Insider	Sell	27,068	$25.97	$702,955.96	74,455
2/1/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$22.00	$48,400.00
1/2/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$22.11	$48,642.00
12/22/2023	William Guyer	Insider	Sell	10,000	$32.00	$320,000.00	6,643
12/5/2023	Gary Charles Robb	Insider	Sell	1,381	$26.27	$36,278.87	27,602
12/4/2023	Joseph Douglas Lyon	CAO	Sell	2,432	$26.00	$63,232.00	5,854
12/1/2023	Daniel N. Swisher, Jr.	Director	Sell	2,200	$25.47	$56,034.00
12/1/2023	Joseph Douglas Lyon	CAO	Sell	2,568	$26.00	$66,768.00	5,854
12/1/2023	Sean Maduck	Insider	Sell	25,000	$25.56	$639,000.00	73,291
11/2/2023	Joseph Douglas Lyon	CAO	Sell	3,977	$28.11	$111,793.47	5,854
11/1/2023	Daniel N. Swisher, Jr.	Director	Sell	2,200	$27.96	$61,512.00
11/1/2023	Sean Maduck	Insider	Sell	5,112	$28.08	$143,544.96	73,291
10/10/2023	Sean Maduck	Insider	Sell	18,471	$27.29	$504,073.59	73,291
10/6/2023	Joseph Douglas Lyon	CAO	Sell	2,582	$27.24	$70,333.68	5,854
10/6/2023	Sean Maduck	Insider	Sell	3,498	$27.24	$95,285.52	73,610
10/2/2023	Daniel N. Swisher, Jr.	Director	Sell	2,200	$27.32	$60,104.00
10/2/2023	Joseph Douglas Lyon	CAO	Sell	2,418	$27.25	$65,890.50	5,854
10/2/2023	Sean Maduck	Insider	Sell	3,031	$27.24	$82,564.44	73,610
9/19/2023	Sean Maduck	Insider	Sell	25,000	$32.48	$812,000.00	73,610
9/5/2023	Daniel N. Swisher, Jr.	Director	Sell	2,200	$32.90	$72,380.00
9/1/2023	Daniel N. Swisher, Jr.	Director	Sell	1,550	$32.73	$50,731.50
9/1/2023	Joseph Douglas Lyon	CAO	Sell	5,000	$32.73	$163,650.00	5,132
8/21/2023	Joseph Douglas Lyon	CAO	Sell	4,588	$31.19	$143,099.72	5,132
8/14/2023	David L. Mahoney	Director	Sell	25,000	$30.95	$773,750.00	11,297
8/14/2023	Hazel Hunt	Insider	Sell	20,455	$30.89	$631,854.95	73,146
8/7/2023	Daniel N. Swisher, Jr.	Director	Sell	2,850	$30.14	$85,899.00
8/7/2023	Joseph Douglas Lyon	CAO	Sell	412	$31.22	$12,862.64	4,720
6/6/2023	Joseph Douglas Lyon	CAO	Sell	10,000	$23.60	$236,000.00	5,132
5/9/2023	Gary Charles Robb	Insider	Sell	30,000	$23.87	$716,100.00	33,997
12/1/2022	Sean Maduck	Insider	Sell	625	$25.28	$15,800.00	56,462
11/22/2022	Gary Charles Robb	Insider	Sell	4,814	$26.03	$125,308.42	21,329
11/17/2022	Gary Charles Robb	Insider	Sell	10,000	$26.06	$260,600.00	39,544
11/10/2022	Sean Maduck	Insider	Sell	25,000	$25.57	$639,250.00	56,462
10/3/2022	Sean Maduck	Insider	Sell	25,000	$25.64	$641,000.00	56,462
9/7/2022	Gary Charles Robb	Insider	Sell	50,000	$26.06	$1,303,000.00	49,544
8/9/2022	Sean Maduck	Insider	Sell	200	$28.70	$5,740.00	40,024
7/18/2022	Sean Maduck	Insider	Sell	25,000	$27.37	$684,250.00	40,024
7/6/2022	Gary Charles Robb	Insider	Sell	45,000	$26.00	$1,170,000.00	24,123
7/6/2022	Joseph K. Belanoff	CEO	Sell	279,908	$26.27	$7,353,183.16	2,538,218
5/19/2022	Gary Charles Robb	Insider	Sell	6,127	$19.57	$119,905.39	36,446
5/17/2022	Gary Charles Robb	Insider	Sell	28,745	$19.55	$561,964.75	42,701
3/17/2022	Gary Charles Robb	Insider	Sell	7,512	$24.68	$185,396.16

See Full Table

SEC Filings (Institutional Ownership Changes) for Corcept Therapeutics (NASDAQ:CORT)

93.61% of Corcept Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Corcept Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/3/2025	Cim LLC	12,300	$0.62M	0.1%	-20.4%	0.012%
2/20/2025	Mackenzie Financial Corp	6,207	$0.31M	0.0%	-3.7%	0.006%
2/19/2025	Cache Advisors LLC	7,500	$0.38M	0.1%	N/A	0.007%
2/19/2025	Public Employees Retirement System of Ohio	2,859	$0.14M	0.0%	+269.9%	0.003%
2/18/2025	Vise Technologies Inc.	4,046	$0.20M	0.0%	N/A	0.004%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	224,713	$11.32M	0.0%	+11.1%	0.214%
2/17/2025	Voloridge Investment Management LLC	471,623	$23.77M	0.1%	-24.2%	0.450%
2/17/2025	Vident Advisory LLC	109,778	$5.53M	0.1%	-5.3%	0.105%
2/17/2025	Two Sigma Advisers LP	381,800	$19.24M	0.0%	-16.5%	0.364%
2/17/2025	Two Sigma Investments LP	202,528	$10.21M	0.0%	-43.1%	0.193%
2/17/2025	Teza Capital Management LLC	4,210	$0.21M	0.0%	N/A	0.004%
2/17/2025	Tanaka Capital Management Inc.	111,551	$5.62M	12.9%	-0.5%	0.106%
2/17/2025	Sherbrooke Park Advisers LLC	5,620	$0.28M	0.1%	N/A	0.005%
2/17/2025	Rafferty Asset Management LLC	5,906	$0.30M	0.0%	-48.7%	0.006%
2/17/2025	Raiffeisen Bank International AG	2,000	$0.10M	0.0%	N/A	0.002%
2/17/2025	ProShare Advisors LLC	24,596	$1.24M	0.0%	+43.8%	0.023%
2/17/2025	Quantedge Capital Pte Ltd	4,800	$0.24M	0.1%	N/A	0.005%
2/17/2025	Man Group plc	287,880	$14.51M	0.0%	-17.9%	0.275%
2/17/2025	Nuveen Asset Management LLC	220,679	$11.12M	0.0%	-0.6%	0.211%
2/17/2025	Occudo Quantitative Strategies LP	5,600	$0.28M	0.1%	N/A	0.005%
2/17/2025	OMERS ADMINISTRATION Corp	44,500	$2.24M	0.0%	-54.3%	0.042%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	46,033	$2.32M	0.0%	+4.0%	0.044%
2/17/2025	Lazard Asset Management LLC	20,000	$1.01M	0.0%	+7.6%	0.019%
2/17/2025	Jacobs Levy Equity Management Inc.	1,376,881	$69.38M	0.2%	+12.5%	1.314%
2/17/2025	Janus Henderson Group PLC	301,490	$15.19M	0.0%	-7.0%	0.288%
2/17/2025	Gen Wealth Partners Inc	1,325	$67K	0.0%	N/A	0.001%
2/17/2025	Gotham Asset Management LLC	19,137	$0.96M	0.0%	+2.8%	0.018%
2/17/2025	Graham Capital Management L.P.	13,281	$0.67M	0.0%	-38.2%	0.013%
2/17/2025	Focus Partners Wealth	33,073	$1.67M	0.0%	+2.1%	0.032%
2/17/2025	Ensign Peak Advisors Inc	47,929	$2.42M	0.0%	+29.9%	0.046%
2/17/2025	Deutsche Bank AG	73,600	$3.71M	0.0%	+48.5%	0.070%
2/17/2025	D. E. Shaw & Co. Inc.	886,576	$44.68M	0.0%	+12.5%	0.846%
2/17/2025	EP Wealth Advisors LLC	7,000	$0.35M	0.0%	+7.3%	0.007%
2/17/2025	Corton Capital Inc.	5,904	$0.30M	0.2%	N/A	0.006%
2/17/2025	Cresset Asset Management LLC	99,975	$5.04M	0.0%	+23.3%	0.095%
2/17/2025	Crestline Management LP	13,774	$0.69M	0.0%	+50.4%	0.013%
2/17/2025	Cetera Investment Advisers	22,048	$1.11M	0.0%	-18.6%	0.021%
2/17/2025	Centiva Capital LP	5,419	$0.27M	0.0%	N/A	0.005%
2/17/2025	Bosun Asset Management LLC	7,095	$0.36M	0.2%	N/A	0.007%
2/17/2025	Brevan Howard Capital Management LP	8,423	$0.42M	0.0%	N/A	0.008%
2/17/2025	Capstone Investment Advisors LLC	8,862	$0.45M	0.0%	-91.5%	0.008%
2/17/2025	Captrust Financial Advisors	113,988	$5.74M	0.0%	+9.9%	0.109%
2/17/2025	Caxton Associates LP	10,632	$0.54M	0.0%	N/A	0.010%
2/17/2025	Balyasny Asset Management L.P.	9,480	$0.48M	0.0%	-27.0%	0.009%
2/17/2025	Bayesian Capital Management LP	6,087	$0.31M	0.0%	N/A	0.006%
2/17/2025	Bank of America Corp DE	98,654	$4.97M	0.0%	-38.9%	0.094%
2/17/2025	BNP Paribas Financial Markets	57,830	$2.91M	0.0%	-42.2%	0.055%
2/17/2025	Ameriprise Financial Inc.	317,318	$15.99M	0.0%	-19.1%	0.303%
2/17/2025	Algert Global LLC	39,328	$1.98M	0.0%	-2.0%	0.038%
2/17/2025	Ancora Advisors LLC	16,188	$0.82M	0.0%	+2,653.1%	0.015%
2/17/2025	AXA S.A.	29,840	$1.50M	0.0%	+204.0%	0.028%
2/14/2025	FAS Wealth Partners Inc.	309,207	$15.58M	1.3%	-2.1%	0.295%
2/14/2025	Comerica Bank	38,641	$1.95M	0.0%	+1.6%	0.037%
2/14/2025	AQR Capital Management LLC	276,591	$13.94M	0.0%	-12.5%	0.264%
2/14/2025	Northern Trust Corp	1,015,515	$51.17M	0.0%	+10.2%	0.969%
2/14/2025	The Manufacturers Life Insurance Company	49,759	$2.51M	0.0%	-2.4%	0.047%
2/14/2025	Aquatic Capital Management LLC	34,534	$1.74M	0.0%	+104.3%	0.033%
2/14/2025	Susquehanna Fundamental Investments LLC	33,097	$1.67M	0.0%	N/A	0.032%
2/14/2025	Nebula Research & Development LLC	11,578	$0.58M	0.1%	N/A	0.011%
2/14/2025	Hancock Whitney Corp	18,221	$0.92M	0.0%	-20.6%	0.017%
2/14/2025	Voya Investment Management LLC	222,750	$11.22M	0.0%	+1.4%	0.213%
2/14/2025	Syon Capital LLC	6,848	$0.35M	0.0%	+11.7%	0.007%
2/14/2025	Coppell Advisory Solutions LLC	2,720	$0.14M	0.0%	+139.9%	0.003%
2/14/2025	Price T Rowe Associates Inc. MD	54,753	$2.76M	0.0%	+3.4%	0.052%
2/14/2025	Massar Capital Management LP	29,192	$1.47M	1.7%	N/A	0.028%
2/14/2025	Hsbc Holdings PLC	27,415	$1.38M	0.0%	-49.6%	0.026%
2/14/2025	Stifel Financial Corp	62,782	$3.16M	0.0%	-29.4%	0.060%
2/14/2025	State of Tennessee Department of Treasury	41,470	$2.09M	0.0%	-5.3%	0.040%
2/14/2025	Tower Research Capital LLC TRC	9,109	$0.46M	0.0%	+426.8%	0.009%
2/14/2025	MetLife Investment Management LLC	48,844	$2.46M	0.0%	+4.7%	0.047%
2/14/2025	Dimensional Fund Advisors LP	2,078,568	$104.74M	0.0%	-17.9%	1.984%
2/14/2025	First Trust Advisors LP	1,064,122	$53.62M	0.0%	-19.3%	1.016%
2/13/2025	CANADA LIFE ASSURANCE Co	104,734	$5.27M	0.0%	+17.8%	0.100%
2/13/2025	Canada Pension Plan Investment Board	800	$40K	0.0%	N/A	0.001%
2/13/2025	Jump Financial LLC	14,242	$0.72M	0.0%	N/A	0.014%
2/13/2025	Guggenheim Capital LLC	5,575	$0.28M	0.0%	N/A	0.005%
2/13/2025	XTX Topco Ltd	13,657	$0.69M	0.1%	N/A	0.013%
2/13/2025	Mariner LLC	13,362	$0.67M	0.0%	+13.6%	0.013%
2/13/2025	Summit Investment Advisors Inc.	8,459	$0.43M	0.4%	+3.3%	0.008%
2/13/2025	Kennedy Capital Management LLC	50,651	$2.55M	0.1%	-0.5%	0.048%
2/13/2025	Capital Fund Management S.A.	121,006	$6.10M	0.0%	-19.3%	0.115%
2/13/2025	Advisory Services Network LLC	15,658	$0.79M	0.0%	-24.1%	0.015%
2/13/2025	Renaissance Technologies LLC	6,198,602	$312.35M	0.5%	-4.8%	5.916%
2/13/2025	Shelton Capital Management	128,914	$6.50M	0.2%	-7.8%	0.123%
2/13/2025	Invesco Ltd.	706,133	$35.58M	0.0%	-17.6%	0.674%
2/13/2025	Bank of Montreal Can	13,678	$0.69M	0.0%	+8.9%	0.013%
2/13/2025	Cerity Partners LLC	607,946	$30.60M	0.1%	-0.6%	0.580%
2/13/2025	Federated Hermes Inc.	13,870	$0.70M	0.0%	+107.1%	0.013%
2/13/2025	Quadrant Capital Group LLC	2,969	$0.15M	0.0%	+9.5%	0.003%
2/13/2025	Russell Investments Group Ltd.	202,504	$10.20M	0.0%	+11.7%	0.193%
2/13/2025	Envestnet Asset Management Inc.	29,157	$1.47M	0.0%	-14.7%	0.028%
2/13/2025	Aviva PLC	10,956	$0.55M	0.0%	-36.8%	0.010%
2/13/2025	KCM Investment Advisors LLC	54,655	$2.75M	0.1%	-4.8%	0.052%
2/13/2025	Wells Fargo & Company MN	90,137	$4.54M	0.0%	+104.5%	0.086%
2/13/2025	Integrated Quantitative Investments LLC	21,600	$1.09M	0.5%	N/A	0.021%
2/12/2025	Atlas Capital Advisors Inc.	10,905	$0.55M	0.1%	N/A	0.010%
2/12/2025	Pitcairn Co.	4,138	$0.21M	0.0%	N/A	0.004%
2/12/2025	Trexquant Investment LP	65,113	$3.28M	0.0%	N/A	0.062%
2/12/2025	Headlands Technologies LLC	1,117	$56K	0.0%	-84.4%	0.001%
2/12/2025	Geode Capital Management LLC	2,068,175	$104.24M	0.0%	-13.1%	1.974%

Data available starting January 2016

See Full Table

Corcept Therapeutics Incorporated engages in discovery and development of drugs for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. It offers Korlym tablets medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous cushing's syndrome; and who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. The company is also developing relacorilant, which is in phase III clinical trial for the treatment of cushing's syndrome; treatment for adrenal cancer and cortisol excess which is in phase 1b clinical trial; treatment for prostate cancer which is in phase II clinical trial; and nab-paclitaxel in combination with relacorilant, which is in phase III clinical trial to treat platinum-resistant ovarian tumors. In addition, it develops dazucorilant, which is in phase II clinical trial for the treatment of amyotrophic lateral sclerosis; miricorilant, which is in phase IIb trial for the treatment of nonalcoholic steatohepatitis; and treatment for antipsychotic induced weight gain that is in phase I trial. The company was incorporated in 1998 and is headquartered in Menlo Park, California.

Today's Range

Now: $54.85

$54.18

$55.55

50 Day Range

MA: $60.64

$49.85

$73.61

52 Week Range

Now: $54.85

$20.84

$75.00

Volume

691,744 shs

Average Volume

1,041,422 shs

Market Capitalization

$5.79 billion

P/E Ratio

43.53

Dividend Yield

N/A

Beta

0.61

Who are the company insiders with the largest holdings of Corcept Therapeutics?: Corcept Therapeutics' top insider investors include:
Joseph K Belanoff (CEO)
Sean Maduck (Insider)
Hazel Hunt (Insider)
Gary Charles Robb (Insider)
David L Mahoney (Director)
Joseph Douglas Lyon (Insider)
Joseph Douglas Lyon (CAO)
William Guyer (Insider)
Daniel N Swisher, Jr (Director)
Learn More about top insider investors at Corcept Therapeutics.
Who are the major institutional investors of Corcept Therapeutics?: Corcept Therapeutics' top institutional shareholders include:
Vanguard Group Inc. — 9.65%
Renaissance Technologies LLC — 5.92%
Parallel Advisors LLC — 3.66%
Dimensional Fund Advisors LP — 1.98%
Geode Capital Management LLC — 1.97%
Arrowstreet Capital Limited Partnership — 1.57%
Learn More about top institutional investors of Corcept Therapeutics stock.
Which institutional investors are selling Corcept Therapeutics stock?: During the last quarter, CORT stock was sold by these institutional investors:
Boston Trust Walden Corp
Dimensional Fund Advisors LP
Geode Capital Management LLC
Renaissance Technologies LLC
First Trust Advisors LP
abrdn plc
Two Sigma Investments LP
Invesco Ltd.
During the previous year, company insiders that have sold Corcept Therapeutics company stock include:
Joseph K Belanoff (CEO)
Sean Maduck (Insider)
Hazel Hunt (Insider)
Gary Charles Robb (Insider)
David L Mahoney (Director)
Joseph Douglas Lyon (Insider)
Learn More investors selling Corcept Therapeutics stock.
Which institutional investors are buying Corcept Therapeutics stock?: In the previous quarter, CORT stock was bought by institutional investors including:
Norges Bank
Point72 Asset Management L.P.
Braun Stacey Associates Inc.
Synergy Asset Management LLC
Raymond James Financial Inc.
Jacobs Levy Equity Management Inc.
Vanguard Group Inc.
Barclays PLC